SCHEMBL6154261

SCHEMBL6154261

Nc1cccc(SCCCc2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.55
MAOA P21397 5/20 0.55
SIGMAR1 Q99720 1/20 0.47
MCL1 Q07820 1/20 0.47
BCL2A1 Q16548 1/20 0.47
LTB4R Q15722 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HIF1A Q16665 1/20 0.45
CYP19A1 P11511 1/20 0.44
NOS1 P29475 1/20 0.44
IDO1 P14902 1/20 0.42
CA2 P00918 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1932895 0.82 CYP1A2 (0.62) MAOBMAOASIGMAR1CYP1A2CYP3A4
SCHEMBL11705911 0.81 MAOB (0.62) MAOBMAOASIGMAR1MCL1BCL2A1
SCHEMBL6154248 0.80 CYP1A2 (0.45) MAOBMAOAMCL1BCL2A1CYP1A2
SCHEMBL3390318 0.80 MAOA (0.45) MAOBMAOASIGMAR1MCL1BCL2A1
SCHEMBL11839797 0.80 MCL1 (0.57) MAOBMAOAMCL1BCL2A1CYP1A2
SCHEMBL31441986 0.79 MAOB (0.52) MAOBMAOALTB4RCYP3A4ALDH1A1
SCHEMBL1323306 0.79 MAOB (0.52) MAOBMAOALTB4RCYP3A4ALDH1A1
SCHEMBL424970 0.77 TSHR (0.49) MAOBMAOACYP3A4ALDH1A1
SCHEMBL9560135 0.77 TSHR (0.41) MAOBMAOALTB4RCYP3A4CA2
SCHEMBL1710556 0.77 HTR6 (0.56) MAOBMAOASIGMAR1MCL1BCL2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP MAOB 3660/4885MAOA 4410/4885SIGMAR1 2793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.